Maryland Capital Management Abb Vie Inc. Transaction History

Maryland Capital Management

$1.2 Billion
Q3 2022

A detailed history of Maryland Capital Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Maryland Capital Management holds 105,285 shares of ABBV stock, worth $17.7 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

105,285

Previous 105,980 0.66%

Holding current value

$17.7 Million

Previous $16.2 Million 12.95%

% of portfolio

1.18%

Previous 1.28%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $93,275 - $106,981	-695 Reduced 0.66%	105,285 $14.1 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $276,478 - $351,494	-2,009 Reduced 1.86%	105,980 $16.2 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $260,000 - $322,587	-1,970 Reduced 1.79%	107,989 $17.5 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $188,861 - $238,964	1,758 Added 1.62%	109,959 $14.9 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $817,152 - $927,590	7,680 Added 7.64%	108,201 $11.7 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $380,334 - $423,714	3,615 Added 3.73%	100,521 $11.3 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $430,069 - $473,454	4,204 Added 4.53%	96,906 $10.5 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $767,794 - $1.04 Million	9,539 Added 11.47%	92,702 $9.93 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $161,253 - $189,257	1,877 Added 2.31%	83,163 $7.28 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $363,108 - $485,892	4,949 Added 6.48%	81,286 $7.98 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $756,133 - $1.15 Million	11,723 Added 18.14%	76,337 $5.82 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $101,414 - $126,891	1,406 Added 2.22%	64,614 $5.72 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $130,620 - $157,043	2,074 Added 3.39%	63,208 $4.79 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $342,756 - $438,123	5,217 Added 9.33%	61,134 $4.45 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $331,779 - $390,487	4,301 Added 8.33%	55,917 $4.51 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $154,687 - $190,771	1,987 Added 4.0%	51,616 $4.76 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $126,341 - $140,451	1,421 Added 2.95%	49,629 $4.69 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $43,184 - $51,096	-481 Reduced 0.99%	48,208 $4.47 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $627,232 - $839,922	-6,817 Reduced 12.28%	48,689 $4.61 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $201,510 - $220,972	-2,250 Reduced 3.9%	55,506 $5.37 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $33,458 - $42,736	-479 Reduced 0.82%	57,756 $5.13 Million
Q2 2017 Aug 14, 2017	BUY	N/A	58,235	58,235 $4.22 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Maryland Capital Management with notifications on news.

Account

Maryland Capital Management Abb Vie Inc. Transaction History